It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
To do that, the treatment tested must be the same as those treatments claimed successful. That includes dosage, regularity of treatment, the same medications used, etc. If one changes those parameters, one is then testing something else.
There are those who may disagree with your requirements, but do all of those "front line" providers use the same protocols?
That's a lot of variables to deal with. Part of the problem, I suppose. Which part, if any, may have any effect at all.
As I understand it, they all have used similar protocols: a combination of azithromycin, hydroxychloroquine, and zinc; early treatment; and "supporting medical care" (which I assume means hospitalization). Some have included prescription-strength levels of vitamins C and D; I do not know if all have done so.
Yes. But there should be at least some effect shown as a result of treatment in clinical testing. The basic idea being that efficacy is dose dependent, not so much that there a magic threshold or combination of treatments where it suddenly works. That's more like alchemy.
If the treatments differ substantially, there is no way to devise a clinical trial that will verify/dispute all their front-line findings
I think clinical trials often involve varying protocols to determine the most effective (and safe) dosages. Typically around Stage III. But the first thing is to determine if there's any point in going that far.
As for anyone disagreeing with "my requirements" (read scientific requirements), well, their opinion is bunk; they just disqualified themselves from giving any reasonable opinions. It don't work that way (and you of all people should know this).
That's a lot of variables to deal with. Part of the problem, I suppose. Which part, if any, may have any effect at all.
Yes. But there should be at least some effect shown as a result of treatment. Enough to continue testing. The basic idea being that efficacy is dose dependent, not so much that there a magic threshold where it suddenly works.
I think clinical trials often involve varying protocols to determine the most effective (and safe) dosages. Typically around Stage III. But the first thing is to determine if there's any point in going that far.
Yes. That's where the "control" part of controlled comes into the picture.
Some medications were left completely out of the trials that started this thread.
No effect for anyone?
Taking either alone has zero effect. Taking both has proved quite effective.
I don't think there are many (who count) who don't want a treatment to found. But political motivations are not limited to those who do not see retrospective, uncontrolled, and unblinded studies as convincing evidence, much less a "cure."
I want a treatment found... I care not one iota what drug is finally used. I only care about the trials for all potential treatments proceeding without political crap (like that shown in excess in this thread) gumming up the works.
Yes. That's where the "control" part of controlled comes into the picture.
No effect for anyone?
I don't think there are many (who count) who don't want a treatment to found. But political motivations are not limited to those who do not see retrospective, uncontrolled, and unblinded studies as convincing evidence, much less a "cure."
Yes, I know you have not proclaimed the potion to be a cure. But your hyperbole about homicide and evil intent on the part of researchers is just as politically inciting as the claims that hydroxycholoroquine is highly dangerous. Neither stance is helpful in any way.
"All that blabber" is science.
Science related, yes, but irrelevant to the debate here
The opinions of a few local doctors, partisan organisations, of your choosing based on deep political biases are just baseless.
one of me laughing at your pitiful attempts to act
Hydroxychloroquine has been reported to be of some use in treating SARS-2 almost from the first reports of the thing spreading beyond China by the Chinese, several European countries,
research findings by scientists from the German Primate Center (DPZ) in Göttingen, the Charité in Berlin and the University Hospital in Bonn now speak a very clear language: Chloroquine is not suitable for the treatment of SARS-CoV-2 infections. It simply does not work.
Calm down.
originally posted by: TheRedneck
a reply to: Phage
...
It would surprise me if the azithromycin were of consequence; however, I would still want it included if for no other reason than to establish a solid baseline for future trials.
...
I'm really not interested in reading any links from you.
You might as well be a bum lying in a gutter clutching his brown paper bag trying to tell me how to invest.
You are one of the least qualified people I have ever met to speak about
You obviously learned nothing in science class if you did.
All you're doing is embarrassing yourself now.
Of course not Redneck. I don't expect you to. So long as you know the facts are sitting right there, that's all that matters to me in the end. For you, this isn't really about HCQ at the end of the day. I know this.
Objective: To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and azithromycin (the triple therapy) dependent on risk stratification.
Conclusions: Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset with the used triple therapy, including the combination of zinc with low dose hydroxychloroquine, was associated with significantly less hospitalizations and 5 times less all-cause deaths.
Source: Novartis discontinues hydroxychloroquine clinical trial based on slow enrollment, remains committed to pandemic research efforts
Novartis has made the decision to stop and discontinue its sponsored HCQ clinical trial for COVID-19 due to acute enrollment challenges that have made trial completion infeasible. The recruitment challenge facing our HCQ trial has made it unlikely that the clinical team will be able to collect meaningful data in a reasonable timeframe to determine the effectiveness of HCQ in treating patients with COVID-19. No safety issues have been reported, and there are no conclusions on efficacy from the study.
The main problem with this work is that the demographics of the control group are not reported, so we have no idea if they are similar. This them means that we have no idea if the differences in outcomes are because of the treatment, or if they would be expected because of the demographies of the groups.
A subtler point is that the reported age profile of the treatment group is impossible. Group A is aged >60 years, and almost half of the treatment group was in that group. But the IQR was reported as 40-60, so only 25% of the treatment group had an age >60. I hope this was due to excessive rounding, or a similar error that can be corrected.
Do you think these are valid concerns about the retrospective, non-randomized, and un-blinded study?
One of only two possibilities exist: in the actions described by this report, there was a substantial decrease in hospitalizations and deaths from what was expected... or... the authors of the report are lying.